Nitroprusside has 36 known drug interactions based on U.S. FDA drug labeling data. 29 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Articaine Hydrochloride And Epinephrine, Articaine Hydrochloride And Epinephrine Bitartrate, Benzocaine, Butamben, And Tetracaine Hydrochloride. Patients taking Nitroprusside should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 36
- Major
- 29
- Moderate
- 6
Major (29)
- Nitroprusside + Articaine Hydrochloride And Epinephrine— Increased risk of methemoglobinemia when concurrently exposed to articaine.
- Nitroprusside + Articaine Hydrochloride And Epinephrine Bitartrate— Increased risk of developing methemoglobinemia when concurrently exposed to this nitrite.
- Nitroprusside + Benzocaine, Butamben, And Tetracaine Hydrochloride— Increased risk of methemoglobinemia when concurrently exposed to this nitrite oxidizing agent with local anesthetics.
- Nitroprusside + Bupivacaine And Meloxicam— Increased risk of methemoglobinemia when local anesthetics are used concomitantly with nitrates/nitrites.
- Nitroprusside + Bupivacaine Hydrochloride— Increased risk of methemoglobinemia when concurrently exposed with bupivacaine.
- Nitroprusside + Dapsone— Induces methemoglobinemia; concomitant use may increase risk for developing methemoglobinemia.
- Nitroprusside + Dapsone Gel, 5%— Concomitant use may increase risk of developing methemoglobinemia. Monitor closely.
- Nitroprusside + Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, Povidine Iodine— Increased risk of methemoglobinemia when used with ropivacaine.
- Nitroprusside + Lidocaine— Increased risk of methemoglobinemia when used concurrently with lidocaine.
- Nitroprusside + Lidocaine 5%— Nitrite that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
- Nitroprusside + Lidocaine And Capsaicin— Nitrite drug that increases risk of methemoglobinemia when used concurrently with lidocaine and capsaicin patch.
- Nitroprusside + Lidocaine And Prilocaine— Nitrate/nitrite; increased risk of methemoglobinemia when concurrently exposed.
- Nitroprusside + Lidocaine Hydrochloride— Increased risk of methemoglobinemia when used concurrently with lidocaine hydrochloride.
- Nitroprusside + Lidocaine Hydrochloride And Epinephrine Bitartrate— Associated with methemoglobinemia risk when concurrent exposure occurs with local anesthetics.
- Nitroprusside + Lidocaine Hydrochloride And Hydrocortisone Acetate— Increased risk of methemoglobinemia when local anesthetic is concurrently exposed to nitrates/nitrites.
- Nitroprusside + Lidocaine Hydrochloride Monohydrate— Concurrent exposure increases risk of methemoglobinemia in patients administered local anesthetics.
- Nitroprusside + Lidocaine Patch 5%— Increased risk of methemoglobinemia when concurrently exposed; nitrates/nitrites may cause methemoglobinemia when used w…
- Nitroprusside + Lidocaine, Isopropyl Alcohol— Increased risk of methemoglobinemia when used with lidocaine.
- Nitroprusside + Lidocaine, Menthol— Increased risk of methemoglobinemia when lidocaine is concurrently exposed to nitrites.
- Nitroprusside + Lidothol Patch— Increased risk of methemoglobinemia when local anesthetics are concurrently exposed to nitrites.
- Nitroprusside + Marcaine, Lidocaine, Kenalog, Povidone Iodine— Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites.
- Nitroprusside + Mepivacaine Hydrochloride— Concurrent exposure increases risk of methemoglobinemia in patients administered mepivacaine.
- Nitroprusside + Penicillin G Benzathine And Penicillin G Procaine— Increased risk of methemoglobinemia when penicillin is concurrently administered with nitroprusside (a nitrite).
- Nitroprusside + Prilocaine Hcl And Epinephrine— Increased risk of methemoglobinemia when prilocaine is concurrently exposed to nitroprusside.
- Nitroprusside + Prilocaine Hydrochloride— Increased risk of methemoglobinemia when used concurrently with prilocaine.
- Nitroprusside + Ropivacaine Hydrochloride— Increased risk of developing methemoglobinemia when concurrently exposed to nitroprusside.
- Nitroprusside + Triamcinolone Acetonide— Increased risk of methemoglobinemia when concurrently exposed.
- Nitroprusside + Triethanolamine Salicylate— Increased risk of methemoglobinemia when used concurrently with triethanolamine salicylate.
- Nitroprusside + Trubrexa Patch Er— Increased risk of methemoglobinemia when used with Trubrexa Transdermal Patch.
Moderate (6)
- Nitroprusside + Bupivacaine— May increase risk of methemoglobinemia when concurrently exposed with bupivacaine.
- Nitroprusside + Bupivacaine Hydrochloride And Epinephrine Bitartrate— Increased risk of methemoglobinemia when concurrently exposed.
- Nitroprusside + Bupivacaine Hydrochloride With Dextrose— Increased risk of developing methemoglobinemia when concurrently exposed.
- Nitroprusside + Dobutamine— Concomitant use results in higher cardiac output and usually lower pulmonary wedge pressure compared to either drug alon…
- Nitroprusside + Lidocaine And Tetracaine— Nitrate/nitrite that increases risk of methemoglobinemia when used concomitantly with lidocaine and tetracaine.
- Nitroprusside + Marcaine, Kenalog, Povidone Iodine— Increased risk of methemoglobinemia when concurrently exposed to nitrates/nitrites with bupivacaine.